NDC 42571-166

Lamivudine, Nevirapine, and Zidovudine

Lamivudine, Nevirapine, And Zidovudine

Lamivudine, Nevirapine, and Zidovudine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Micro Labs Limited. The primary component is Lamivudine; Nevirapine; Zidovudine.

Product ID42571-166_73d82e59-0f5b-0502-e053-2a91aa0a3f52
NDC42571-166
Product TypeHuman Prescription Drug
Proprietary NameLamivudine, Nevirapine, and Zidovudine
Generic NameLamivudine, Nevirapine, And Zidovudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-09-03
Marketing CategoryNDA / NDA
Application NumberNDA205626
Labeler NameMicro Labs Limited
Substance NameLAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Active Ingredient Strength150 mg/1; mg/1; mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 42571-166-60

60 TABLET, FILM COATED in 1 BOTTLE (42571-166-60)
Marketing Start Date2018-09-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 42571-166-32 [42571016632]

Lamivudine, Nevirapine, and Zidovudine TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205626
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-03
Marketing End Date2019-12-17

NDC 42571-166-29 [42571016629]

Lamivudine, Nevirapine, and Zidovudine TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205626
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-03
Marketing End Date2019-12-17

NDC 42571-166-60 [42571016660]

Lamivudine, Nevirapine, and Zidovudine TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205626
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-03
Marketing End Date2019-12-17

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE150 mg/1

OpenFDA Data

SPL SET ID:aae85037-761c-45f9-bcee-319710528ab7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 687064
  • UPC Code
  • 0342571166601
  • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.